App aims to ease burden for stem cell transplant caregivers

NCT ID NCT04094844

Completed Symptom relief Sponsor: University of Michigan Rogel Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a mobile app called Roadmap 2.0 could improve the quality of life for caregivers and patients undergoing stem cell transplants. Over 370 caregivers and patients used a Fitbit tracker and answered surveys. Some also got the app with extra positive activities. The goal was to see if the app helped caregivers feel better emotionally and physically during a stressful time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Roadmap 2.0 mobile app with optional positive activities
What this could lead to: If it works, this could point toward a simple, low-cost way to support caregivers and patients during stem cell transplant recovery.
What could go wrong: This is a completed trial, but the intervention is a behavioral app—not a drug or cure. Benefits may be modest and not apply to all caregivers or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOLOGIC DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hematologic disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMATOLOGIC DISEASES

Contacts and locations

Locations

Oregon Health & Science University

Portland, Oregon, 97239, United States
University of Michigan Rogel Cancer Center

Ann Arbor, Michigan, 48109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.